These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 31435484)
1. Addressing Decision Making in Progesterone Treatment for History of Preterm Delivery. Zuponcic J; Cottrell C; Lavin J; Facchini W; Li M AJP Rep; 2019 Jul; 9(3):e244-e250. PubMed ID: 31435484 [No Abstract] [Full Text] [Related]
2. Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth. Ning A; Vladutiu CJ; Dotters-Katz SK; Goodnight WH; Manuck TA Am J Obstet Gynecol; 2017 Sep; 217(3):371.e1-371.e7. PubMed ID: 28526452 [TBL] [Abstract][Full Text] [Related]
3. Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis. Boelig RC; Locci M; Saccone G; Gragnano E; Berghella V Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100658. PubMed ID: 35562009 [TBL] [Abstract][Full Text] [Related]
4. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy. Dodd JM; Grivell RM; OBrien CM; Dowswell T; Deussen AR Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012024. PubMed ID: 29086920 [TBL] [Abstract][Full Text] [Related]
5. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy. Dodd JM; Grivell RM; OBrien CM; Dowswell T; Deussen AR Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31745984 [TBL] [Abstract][Full Text] [Related]
6. Pregnancy duration with use of 17-α-hydroxyprogesterone caproate in a retrospective cohort at high risk of recurrent preterm birth. Massa K; Childress K; Vricella LK; Boerrigter A; Franklin BHK; Sauer M; Armbruster R; Tomlinson T Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100219. PubMed ID: 33345927 [TBL] [Abstract][Full Text] [Related]
7. Understanding barriers to uptake of 17 alpha-hydroxyprogesterone caproate (17-OHP) in women with history of preterm birth. Kalata M; Teter K; Wagner L; Swarr V; Witzeman K J Matern Fetal Neonatal Med; 2021 Feb; 34(4):541-546. PubMed ID: 31006296 [No Abstract] [Full Text] [Related]
8. Intramuscular progesterone in women with twins and a prior singleton spontaneous preterm birth. Ward A; Greenberg V; Valcarcel B; Boelig RC; Al-Kouatly HB; Berghella V Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100124. PubMed ID: 33345870 [TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
10. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial. Boelig RC; Schoen CN; Frey H; Gimovsky AC; Springel E; Backley S; Berghella V Am J Obstet Gynecol; 2022 May; 226(5):722.e1-722.e12. PubMed ID: 35189093 [TBL] [Abstract][Full Text] [Related]
15. A chronicle of the 17-alpha hydroxyprogesterone caproate story to prevent recurrent preterm birth. Nelson DB; McIntire DD; Leveno KJ Am J Obstet Gynecol; 2021 Feb; 224(2):175-186. PubMed ID: 33035472 [TBL] [Abstract][Full Text] [Related]
16. Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system. Manuck TA; Stoddard GJ; Fry RC; Esplin MS; Varner MW Am J Obstet Gynecol; 2016 Nov; 215(5):622.e1-622.e8. PubMed ID: 27418444 [TBL] [Abstract][Full Text] [Related]
17. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth. Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230 [TBL] [Abstract][Full Text] [Related]
19. Adherence rates and outcomes for 17-hydroxyprogesterone caproate use in women with a previous history of preterm birth. Edwards AM; Lowry SA; Mikovich S; Forinash AB; Babbar S Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100166. PubMed ID: 33345885 [TBL] [Abstract][Full Text] [Related]